Active	Status	Sponsor type	Region	Phase	Filter
8 Active 0 Inactive 8 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

8 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Monnin, Katy
NCT05143177: A Study to Evaluate the Efficacy and Safety of DA-1229 (Evogliptin) in Patient's Calcific Aortic Valve Disease with Mild to Moderate Aortic Stenosis (EVOID-AS)	Active, not recruiting	2/3	867	Canada, US	Evogliptin, DA-1229, Placebo	REDNVIA Co., Ltd.	Calcific Aortic Valve Disease	05/26	12/26
CLASP IID, NCT03706833: Edwards PASCAL /IIF Pivotal Clinical Trial	Recruiting	N/A	1247	Europe, Canada, US	Edwards PASCAL System, Transcatheter Mitral Valve repair (TMVr), Abbott Mitraclip System	Edwards Lifesciences	Degenerative Mitral Valve Disease, Mitral Regurgitation, Mitral Insufficiency, Functional Mitral Regurgitation	01/25	04/30
TWIST-EFS, NCT04919980: TVMR with the Innovalve System Trial - Early Feasibility Study	Recruiting	N/A	65	US	Innovalve MR system	Innovalve Bio Medical Ltd.	Mitral Valve Regurgitation (Degenerative or Functional)	07/25	07/30
Toro, Taylor
NCT05143177: A Study to Evaluate the Efficacy and Safety of DA-1229 (Evogliptin) in Patient's Calcific Aortic Valve Disease with Mild to Moderate Aortic Stenosis (EVOID-AS)	Active, not recruiting	2/3	867	Canada, US	Evogliptin, DA-1229, Placebo	REDNVIA Co., Ltd.	Calcific Aortic Valve Disease	05/26	12/26
CLASP IID, NCT03706833: Edwards PASCAL /IIF Pivotal Clinical Trial	Recruiting	N/A	1247	Europe, Canada, US	Edwards PASCAL System, Transcatheter Mitral Valve repair (TMVr), Abbott Mitraclip System	Edwards Lifesciences	Degenerative Mitral Valve Disease, Mitral Regurgitation, Mitral Insufficiency, Functional Mitral Regurgitation	01/25	04/30
MVSS, NCT04736667: Mitral Valve Screening Survey	Recruiting	N/A	1000	Canada, US		Medstar Health Research Institute	Mitral Valve Disease	02/27	02/27
Worley, Amy
NCT05143177: A Study to Evaluate the Efficacy and Safety of DA-1229 (Evogliptin) in Patient's Calcific Aortic Valve Disease with Mild to Moderate Aortic Stenosis (EVOID-AS)	Active, not recruiting	2/3	867	Canada, US	Evogliptin, DA-1229, Placebo	REDNVIA Co., Ltd.	Calcific Aortic Valve Disease	05/26	12/26
ADVANTAGE AF, NCT05443594: A Prospective Single Arm Open Label Study of the FARAPULSE Pulsed Field Ablation System in Subjects with Persistent Atrial Fibrillation	Active, not recruiting	N/A	669	Europe, Canada, US	Phase 1: FARAPULSE Ablation System, Phase 2: FARAPULSE Ablation System	Boston Scientific Corporation	Persistent Atrial Fibrillation	03/25	03/25